February 25, 2014

ISAPP will meet March 5 with FDA’s Center for Food Safety and Applied Nutrition to discuss conducting human research on foods. The FDA made it clear in a guidance from September 2013 that human research conducted on functional endpoints for foods requires an investigational new drug (IND) application. However, the FDA re-opened the comment period on that guidance, and ISAPP – along with American Society of Nutrition, Institute of Food Technologists and ILSI-North America – will share concerns with CFSAN that the IND requirement for food research is misguided. As succinctly stated by Dr. James Heimbach, who will be representing ISAPP at the meeting, “A substance can’t be an investigational new drug unless it is a drug, and FDA is attempting to declare legitimate food ingredients that provide benefits other than taste or aroma to be drugs.” See related posts from February 5, 2014, November 26, 2013 and September 25, 2013.

February 24, 2014

On February 11, ISAPP, represented by Mary Ellen Sanders (executive director), Daniel Merenstein, Greg Leyer (Sr. ISAPP-IAC representative) and Chris Cifelli (Jr. ISAPP-IAC representative), met with Mr. Richard Cleland, Assistant Director, Division of Advertising Practices with the Federal Trade Commission to gain a better understanding of FTCs perspective on conducting research intended to substantiate structure/function or health claims for foods in the United States. Mr. Cleland’s forthright approach in his responses was much appreciated. This report itemizes the questions posed by ISAPP and summarizes the responses provided by Mr. Cleland.

February 5, 2014

The FDA is re-opening comments on portions of its Guidance on Determining if Human Research Studies Require an Investigational New Drug Application. ISAPP intends to file comments reflecting concerns that the current guidance (published in final form September 2013) unduly restricts human research on functional properties of foods and supplements, harming U.S. researchers, consumers and industry. Comments due to the FDA April 7, 2014. Submit comment. See related Latest News posts on September 25, 2013 and November 26, 2013.

January 10, 2014

World Gastroenterology Organisation released a new webcast “Irritable Bowel Syndrome (IBS): What is it, what causes it and can I do anything about it?”; an educational program for the general public. The webcast was developed from the WGO World Digestive Health Day 2012 Campaign and covers the following topics: What is IBS?, How to communicate symptoms to help the doctor make the right diagnoses, Progress in IBS, Could it be something else?, What can I do to deal with my symptoms?, How about diet or dietary supplements?, Managing IBS, and Living with IBS.

January 9, 2014

U.S. Pharmacopeia (USP) is accepting comments on a proposed monograph for testing the identity, concentration and purity of Bacillus coagulans GBI-30, 6086. As the first probiotic monograph with USP, this is a noteworthy development. USP press release. USP Food Ingredients.

January 7, 2014

Law firm expresses concern that the FDA seeks to greatly constrict medical food category in the United States. See blog post by Hyman, Phelps & McNamara, P.C., Medical Food Draft Guidance – Has the FDA Bitten off More than it Can Chew?

November 26, 2013

ISAPP is signatory, along with other professional societies, on a letter requesting that the FDA retract its final guidance (issued September 2013) on when food and dietary supplement research must be conducted under and Investigational New Drug Application. A face-to-face meeting with the FDA was also requested. Letter. (See also ISAPP Latest News post on September 25, 2013 below).

November 18, 2013

This week in Nairobi, Kenya, ISAPP Board member, Dr. Gregor Reid, will lead an International Conference and Workshop on the Microbiome and Probiotics. Hosted at the International Livestock Research Institute (ILRI), the event is supported by ISAPP and sponsored by the Maternal-Infant Microbiome and Immunity (MIMI) Canadian Institutes for Health Network and the Ministry of Agriculture, Kenya. read more …

October 25, 2013

An expert panel addressing proper use of the term “probiotic” was convened by ISAPP October 24, 2013 in London UK. The panel, chaired by Prof. Glenn Gibson, comprised 10 academic experts and ISAPP’s executive director. A fast-track manuscript indicating conclusions from the discussion is being prepared by the panelists. Although the panel agreed to continue endorsement of the FAO/WHO 2001 definition of probiotics, the manuscript will discuss how research and developments over the past 12 years since the definition was proposed impact today’s implementation of the word ‘probiotic’ by all stakeholders. The Panel

December 17, 2012

See the newly released report from the ISAPP meeting held in Cork, Ireland October 1-3, 2012. Download meeting report

December 8, 2012

The Global Probiotics Council, a committee established in 2004 by DANONE Research and Yakult Honsha Co., Ltd., announced the 6th annual Young Investigator Grant for Probiotics Research. Three $50,000 annual grants will support new research on probiotics and gastrointestinal microbiota in the United States. Young Investigators committed to basic research on gastrointestinal microbiota, probiotics and their role in health and wellness should apply (by February 12, 2013). Information.

November 12, 2012

The term “probiotic” will no longer be allowed on food labels in the EU starting December 14, 2012. EFSA has remained unconvinced that the strength of the science behind probiotic products meets their efficacy standards. Conferring a health benefit is imbedded in the term, “probiotic;” therefore, the term can only be used on products with an approved health benefit. NUTRAingredients article.

October 31, 2012

The ISAPP Board of Directors responds to the accusation of publication bias in the field of probiotic research: no evidence that publication bias for probiotic field is any different than other fields. ISAPP calls for publication of all studies (positive, negative or null) and full disclosure of conflicts of interest. Open letter.

October 1, 2012

ISAPP sponsors speakers at first Probiotic Association of India conference in New Delhi. Report.

September 14, 2012

Science Friday radio interview with Susan Lynch, UCSF, on microbial colonization of healthy sinuses, “Microbes benefit more than just the gut.

August 30, 2012

Webcast now available: “The New Microbiota & Probiotics Paradigm: from Mechanisms to Clinical Applications”, featuring the following lectures and Q&A:

July 31, 2012

Students (undergraduates and graduates), post-doctoral fellows and residents can submit probiotic studies to Digestive Disease Week and compete for cash prizes as part of the Probiotic Challenge, sponsored by Lallemand Human Nutrition and the American Gastroenterological Association (AGA) Institute. The Challenge aims to stimulate research in probiotics. Abstracts are due to DDW December 1, 2012.

April 17, 2012

Lallemand Human Nutrition, in partnership with the American Gastroenterological Association, announced a new edition of the “Probiotic Challenge,” a competition for students working on probiotic research. If selected by the AGA and a team of judges, winners can present their study at DDW2013 and win cash prizes.

April 16, 2012

National Public Radio interview with John Cryan, professor at University College Cork in Ireland, on study published in PNAS showing that Lactobacillus rhamnosus JB-1 reduced anxiety and depression-like behaviors in stressed mice.

April 11, 2012

Probiotic industry members, Valio, Danone, Yakult, Chr Hansen, DuPont-Danisco, Probi and Lallemand formed the Global Alliance for Probiotics (GAP) to collaborate on defining a path forward for health claims for probiotics in the European Union. Read Nutraingredients article.

February 26, 2012

The Institute of Medicine held a workshop February 22-23, 2012 on The Human Microbiome, Diet, and Health. Slides from this forum will be posted March 2 and a written summary of conclusions will be published.

February 24, 2012

FDA’s Center for Biologic Evaluation and Research (CBER) issued a finalized guidance for industry on when an Investigational New Drug (IND) application is required for human research on live biotherapuetic agents. The draft guidance on a similar topic issued by CBER and the Center for Drug Evaluation and Research (CDER) October 2010 has not been finalized. This final guidance acknowledges that live microbes (probiotics) intended for use as foods or dietary supplements can be investigated with human studies without an IND. The new guidance falls short of acknowledging an IND-free research path for human studies on medical foods, foods for special dietary uses or to research a food Health Claim. Foods or dietary supplements being studied for drug purposes (cure, mitigate, treat, diagnose, or prevent disease) will require an IND.

February 21, 2012

The Dannon Company announces the Dannon Probiotics Fellow Program to support the education of a student who excels in science and shows a strong interest in probiotics studies. The winner receives a scholarship equivalent to one year’s tuition (up to $25,000, payable to the educational institution) and an all-expense paid trip to the Danone Research Center in France. Application deadline is March 31, 2012. Information.